MedTrace Logo

Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA

NCT04732637 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-03-30

No results posted yet for this study

Summary

Nasopharyngeal Swabs (NPS) used to test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection can cause mild to severe discomfort in addition to increasing the risk of transmission. The present study evaluates Test At Home's proprietary self-collection method based on a chewable buccal cavity swab ("lollipop") that stimulates oral fluid collection. The novel method is compared against a contemporary nasal swab collected by a qualified healthcare worker.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Test At Home's Proprietary "Lollipop" Buccal Cavity Swab

Self-collected Test At Home's proprietary "Lollipop" Buccal Cavity Swab with VTM.

Sponsors & Collaborators

Principal Investigators

  • Vivek Manoharan, PhD · Test At Home Pte. Ltd., Singapore - India.

  • Paul Macary, PhD · National University of Singapore

  • Saket Jhajharia, PhD · Test At Home Pte. Ltd., Singapore - India

  • Terence Tan, MBBS · Test At Home Pte. Ltd., Singapore - India.

  • Vineet Datta, MD · Datar Cancer Genetics Limited, United Kingdom - India

  • Kanupriya Batra, MBA · Test At Home Pte. Ltd., Singapore - India.

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-05-31
Completion
2021-08-31

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04732637 on ClinicalTrials.gov